tiprankstipranks
Arbutus Biopharma Corporation (GB:0SGC)
LSE:0SGC

Arbutus Biopharma (0SGC) Balance Sheet

0 Followers

Arbutus Biopharma Balance Sheet

Arbutus Biopharma's total assets for Q4 2023 were $144.40M, a decrease of -8.98% from the previous quarter. GB:0SGC total liabilities were $38.38M for the fiscal quarter, a -2.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 144.40M$ 195.42M$ 204.49M$ 137.08M$ 105.53M
Total Liabilities
$ 38.38M$ 58.57M$ 35.05M$ 35.11M$ 32.79M
Total Equity Gross Minority
$ 106.02M$ 136.85M$ 169.44M$ 101.97M$ 72.74M
Total Capitalization
$ 107.36M$ 136.85M$ 169.44M$ 101.97M$ 72.74M
Preferred Stock Equity
---$ 149.41M$ 137.28M
Capital Lease Obligations
---$ 2.98M$ 3.36M
Currency in USD

Arbutus Biopharma Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis